Your account is not claimed yet. You can sign up with ORCID to claim your account.

Keiji Nogami (K Nogami)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 44

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Pediatrics international : official journal of the Japan Pediatric Society

BMJ open

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Shinobu Tamura, Hitoshi Ohno, Satoshi Higasa, Naruto Shimonishi, Yuto Nakajima, Tomoko Onishi, Keiji Nogami
Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot ® ) evaluated by global coagulation assay in patients with acquired haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Tomoko Onishi, Suguru Harada, Hanako Shimo, Yoshihito Tashiro, Tetsuhiro Soeda, Keiji Nogami
The in vitro effect of anticoagulant agents on coagulation and fibrinolysis in the presence of emicizumab in the plasmas from patients with haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Masahiro Takeyama, Naoki Ozu, Shu Kasama, Masato Kasahara, Masanori Matsumoto, Midori Shima, Keiji Nogami
Study protocol for assessment of the coagulation potential of concomitantly used factor VIII concentrates in patients with haemophilia A with emicizumab prophylaxis (CAGUYAMA Study): a multicentre open-label non-randomised clinical trial. BMJ open 13 (7) (2023)
Kuniyoshi Mizumachi, Yuto Nakajima, Naruto Shimonishi, Shoko Furukawa, Kenichi Ogiwara, Masahiro Takeyama, Keiji Nogami
Hybrid human-porcine factor VIII proteins partially escape the inhibitory effects of anti-factor VIII inhibitor alloantibodies having A2 or C2 domain specificity. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Yuto Nakajima, Kenichi Ogiwara, Naruto Shimonishi, Shoko Furukawa, Masahiro Takeyama, Keiji Nogami
Intra-articular haemorrhage caused by reduced recovery of PEGylated recombinant factor VIII due to an anti-PEG antibody developed after mRNA-1273 SARS-CoV-2 vaccination in haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Yuya Mawarikado, Asuka Sakata, Yusuke Inagaki, Daisuke Shirai, Kohei Tatsumi, Keiji Nogami, Yasuhito Tanaka, Akira Kido, Midori Shima
Single-facility study of the effectiveness of rehabilitation therapy using wearable hybrid assistive limb for patients with bleeding disorders: study protocol for a randomised controlled trial. BMJ open 13 (11) (2023)
Masahiro Takeyama, Shoko Furukawa, Kenichi Ogiwara, Keiji Nogami
First case report of hematidrosis complicated with type 1 von Willebrand disease. Pediatrics international : official journal of the Japan Pediatric Society 65 (1) (2023)
Takashi Ishihara, Mai Watakabe, Satoshi Ochi, Naohiro Akisada, Keiji Nogami
Early diagnosis of EBF1-PDGFRB-positive acute lymphoblastic leukemia. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Tadashi Matsushita, Nobuaki Suzuki, Azusa Nagao, Chiai Nagae, Haruko Yamaguchi-Suita, Yui Kyogoku, Akiko Ioka, Keiji Nogami
AKATSUKI study: a prospective, multicentre, phase IV study evaluating the safety of emicizumab under and immediately after immune tolerance induction therapy in persons with congenital haemophilia A with factor VIII inhibitors. BMJ open 12 (3) (2022)
Takahiro Yagyuu, Shoko Furukawa, Miki Zaizen, Sachiko Yata, Mitsuhiko Imada, Keiji Nogami, Tadaaki Kirita
Peri-operative hemostatic management of tooth extraction in patients with hemophilia A, with and without inhibitors, receiving emicizumab prophylaxis. Haemophilia : the official journal of the World Federation of Hemophilia (2022)
Keiji Nogami, Midori Shima
Current and future therapies for haemophilia-Beyond factor replacement therapies. British journal of haematology (2022)
Hiroaki Yaoi, Yasuaki Shida, Kenichi Ogiwara, Takehisa Kitazawa, Midori Shima, Keiji Nogami
Emicizumab enhances thrombus formation in vitro under high shear flow conditions in whole blood from patients with type 1 and type 3 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Tomoaki Ishikawa, Yuto Nakajima, Takashi Omae, Kenichi Ogiwara, Keiji Nogami
Comprehensive coagulation and fibrinolytic potential in the acute phase of pediatric patients with idiopathic nephrotic syndrome evaluated by whole blood-based rotational thromboelastometry. Pediatric nephrology (Berlin, Germany) 37 (7) (2022)
Tomoyuki Kamamoto, Yuto Nakajima, Yumiko Uchida, Takashi Nakagawa, Hitoshi Tonegawa, Yuki Tani, Eri Nishimoto, Yukihiro Takahashi, Toshiya Nishikubo, Keiji Nogami
Protein C system in preterm babies with chronic lung disease: Prospective study. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Yuto Nakajima, Eisuke Takami, Hirotoshi Nakano, Keiji Nogami
In vitro evaluation of global coagulation potentials in the co-presence of plasma-derived factors Viia/X products (Byclot ® ) and emicizumab in patients with haemophilia A and inhibitors and acquired haemophilia A: A pilot study. Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Midori Shima, Hideyuki Takedani, Kaoru Kitsukawa, Masashi Taki, Akira Ishiguro, Azusa Nagao, Haruko Yamaguchi-Suita, Yui Kyogoku, Seitaro Yoshida, Keiji Nogami
AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study. BMJ open 12 (6) (2022)
Kenichi Ogiwara, Masashi Taki, Takashi Suzuki, Hideyuki Takedani, Tadashi Matsushita, Kagehiro Amano, Masanori Matsumoto, Kenji Nishio, Midori Shima, Masato Kasahara, Keiji Nogami
Assessment of global coagulation function under treatment with emicizumab concomitantly with bypassing agents in haemophilia A with inhibitor (UNEBI Study): multicentre open-label non-randomised clinical trial. BMJ open 12 (2) (2022)
Makiko Morita, Yasuyuki Arai, Takashi Ishihara, Tomoko Onishi, Hanako Shimo, Kayoko Nakanishi, Yukiko Nishiyama, Tomoyasu Jo, Hidefumi Hiramatsu, Takaya Mitsuyoshi, Chisaki Mizumoto, Junya Kanda, Momoko Nishikori, Toshio Kitawaki, Keiji Nogami, Akifumi Takaori-Kondo, Miki Nagao, Souichi Adachi
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma. Blood advances 6 (14) (2022)
Hitomi Nishioka, Tomoko Onishi, Taito Kitano, Masahiro Takeyama, Natsuko Imakita, Kei Kasahara, Ryuji Kawaguchi, Jennifer Akiko Masaki, Keiji Nogami
A survey of healthcare workers' recommendations about human papillomavirus vaccination. Clinical and experimental vaccine research 11 (2) (2022)
Keiji Nogami, Masashi Taki, Tadashi Matsushita, Tetsuhito Kojima, Toshiaki Oka, Shouichi Ohga, Kiyoshi Kawakami, Michio Sakai, Takashi Suzuki, Satoshi Higasa, Yasuo Horikoshi, Keiko Shinozawa, Shogo Tamura, Koji Yada, Masue Imaizumi, Yoshitoshi Ohtsuka, Fuminori Iwasaki, Masao Kobayashi, Junki Takamatsu, Hideyuki Takedani, Hisaya Nakadate, Yoko Matsuo, Takeshi Matsumoto, Teruhisa Fujii, Katsuyuki Fukutake, Akira Shirahata, Akira Yoshioka, Midori Shima, null null
Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2). Haemophilia : the official journal of the World Federation of Hemophilia 28 (5) (2022)
Mai Watakabe, Yasuaki Shida, Kenichi Ogiwara, Yusuke Inagaki, Keiji Nogami
A mild hemophilia B case with postoperative bleeds following thromboprophylaxis. Pediatrics international : official journal of the Japan Pediatric Society 64 (1) (2022)
Takashi Omae, Tomoaki Ishikawa, Yuto Nakajima, Keiji Nogami
Coagulation Potentials in Pediatric Patients with Immunoglobulin A Nephropathy. Pediatrics international : official journal of the Japan Pediatric Society (2021)
Tomoko Onishi, Takashi Ishihara, Keiji Nogami
Coagulation and fibrinolysis balance in disseminated intravascular coagulation. Pediatrics international : official journal of the Japan Pediatric Society 63 (11) (2021)
Hiroaki Yaoi, Yasuaki Shida, Takehisa Kitazawa, Midori Shima, Keiji Nogami
Emicizumab improves thrombus formation of type 2A von willebrand disease under high shear condition. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Mai Watakabe, Takashi Ishihara, Satoshi Ochi, Midori Shima, Keiji Nogami
Successful unrelated cord blood transplantation for Diamond-Blackfan anemia. Pediatrics international : official journal of the Japan Pediatric Society 63 (3) (2021)
Hirosato Aoki, Kenichi Ogiwara, Mari Hasegawa, Keiji Nogami
Hemostatic rebalance in neonatal intrahepatic cholestasis with citrin deficiency. Pediatrics international : official journal of the Japan Pediatric Society (2021)
Yuto Nakajima, Hitoshi Tonegawa, Mariko Noguchi-Sasaki, Keiji Nogami
Predicted coagulation potential using an in vitro simulated model of emicizumab prophylaxis and immune tolerance induction therapy in hemophilia A patients with inhibitor. International journal of hematology 113 (6) (2021)
Beatrice Nolan, Johnny N Mahlangu, Ingrid Pabinger, Guy Aaron Young, Barbara A Konkle, Chris Barnes, Keiji Nogami, Elena Santagostino, K John Pasi, Liane Khoo, Bent Winding, Huixing Yuan, Joachim Fruebis, Dan Rudin, Johannes Oldenburg
Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Yuto Nakajima, Keiji Nogami
The C-terminal acidic region in the A1 domain of factor VIII facilitates thrombin-catalyzed activation and cleavage at Arg372. Journal of thrombosis and haemostasis : JTH 19 (3) (2020)
Yasuko Furuichi, Keiji Nogami, Koji Yada, Satoko Nezu, Kenji Obayashi, Keigo Saeki, Norio Kurumatani, Mitsuru Nakajima, Seiji Kinoshita, Midori Shima
Assessment of self-/parent-reported quality of life in Japanese children with haemophilia using the Japanese version of KIDSCREEN-52. Haemophilia : the official journal of the World Federation of Hemophilia 26 (2) (2020)
Yuto Nakajima, Koji Yada, Kenichi Ogiwara, Shoko Furukawa, Naruto Shimonishi, Midori Shima, Keiji Nogami
A microchip flow-chamber assay screens congenital primary hemostasis disorders. Pediatrics international : official journal of the Japan Pediatric Society 63 (2) (2020)
Kenichi Ogiwara, Keiji Nogami, Naoki Matsumoto, Mariko Noguchi-Sasaki, Michinori Hirata, Tetsuhiro Soeda, Midori Shima
A modified thrombin generation assay to evaluate the plasma coagulation potential in the presence of emicizumab, the bispecific antibody to factors IXa/X. International journal of hematology 112 (5) (2020)
Midori Shima, Azusa Nagao, Masashi Taki, Tadashi Matsushita, Koichi Oshida, Kagehiro Amano, Sayaka Nagami, Norihiro Okada, Shingo Maisawa, Keiji Nogami
Long-term safety and efficacy of emicizumab for up to 5.8 years and patients' perceptions of symptoms and daily life: A phase 1/2 study in patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 27 (1) (2020)
Shoko Furukawa, Keiji Nogami, Naruto Shimonishi, Yuto Nakajima, Taisei Matsumoto, Midori Shima
Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia A patients with inhibitors. British journal of haematology 190 (5) (2020)
Naruto Shimonishi, Keiji Nogami, Kenichi Ogiwara, Tomoko Matsumoto, Fumie Nakazawa, Tetsuhiro Soeda, Michinori Hirata, Nobuo Arai, Midori Shima
Emicizumab improves the stability and structure of fibrin clot derived from factor VIII-deficient plasma, similar to the addition of factor VIII. Haemophilia : the official journal of the World Federation of Hemophilia 26 (3) (2020)
Yuto Nakajima, Keiji Nogami, Koji Yada, Kenichi Ogiwara, Shoko Furukawa, Naruto Shimonishi, Midori Shima
Whole blood ristocetin-induced platelet impedance aggregometry does not reflect clinical severity in patients with type 1 von Willebrand disease. Haemophilia : the official journal of the World Federation of Hemophilia 25 (3) (2019)
Keiji Nogami, Tomoko Matsumoto, Kana Sasai, Kenichi Ogiwara, Nobuo Arai, Midori Shima
A novel simultaneous clot-fibrinolysis waveform analysis for assessing fibrin formation and clot lysis in haemorrhagic disorders. British journal of haematology 187 (4) (2019)
Yuji Suzuki, Keisuke Kakisaka, Tomoko Matsumoto, Keiji Nogami, Hirokatsu Katagiri, Takeshi Takahara, Yasuhiro Takikawa
Orthotopic liver transplantation for haemophilia A may not always lead to a phenotypic cure of haemophilia A: A case report. Haemophilia : the official journal of the World Federation of Hemophilia 24 (6) (2018)
Keiji Nogami, M Taki, T Matsushita, S Ohga, T Oka, Y Horikoshi, K Amano, M Shima
The Japanese Immune Tolerance Induction (J-ITI) study in haemophilia patients with inhibitor: Outcomes and successful predictors of ITI treatment. Haemophilia : the official journal of the World Federation of Hemophilia 24 (5) (2018)
Keiji Nogami, Tomoko Matsumoto, Koji Yada, Kenichi Ogiwara, Shoko Furukawa, Yasuaki Shida, Masahiro Takeyama, Midori Shima
Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor. British journal of haematology 181 (4) (2018)
Yuka Kondo, Yasuaki Shida, Tomoaki Ishikawa, Koji Yada, Masahiro Takeyama, Midori Shima, Keiji Nogami
A case of moderate haemophilia A with inhibitor, carrying the p.R1800H mutation, complicated with juvenile idiopathic arthritis. Haemophilia : the official journal of the World Federation of Hemophilia 25 (1) (2018)
Koji Yada, Keiji Nogami, Keiko Shinozawa, Takehisa Kitazawa, Kunihiro Hattori, Kagehiro Amano, Katsuyuki Fukutake, Midori Shima
Emicizumab-mediated haemostatic function in patients with haemophilia A is down-regulated by activated protein C through inactivation of activated factor V. British journal of haematology 183 (2) (2018)
Shoko Furukawa, Keiji Nogami, K Ogiwara, K Yada, M Shima
Successful prophylaxis using activated prothrombin complex concentrates (aPCC) in a severe haemophilia A patient with inhibitor previously unresponsive to on-demand daily infusions of aPCC. Haemophilia : the official journal of the World Federation of Hemophilia 23 (5) (2017)
T Matsumoto, Keiji Nogami, Y Tabuchi, K Yada, K Ogiwara, H Kurono, N Arai, M Shima
Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A. Haemophilia : the official journal of the World Federation of Hemophilia 23 (5) (2017)

Keiji Nogami.css-eqlu8i{font-size:small;padding-left:4px;} (K Nogami)

Publication Activity (10 Years)

Top Topics

Top Venues

Keiji Nogami (K Nogami)